Lung disease induced by novel chemotherapeutic agents and biomolecules Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006
Drug-induced pulmonary toxicity in clinical practice Source: Annual Congress 2009 - PG7 Drug-induced pulmonary toxicity Year: 2009
Dermatologic toxicity Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019
The influence phenotype of hydroxylation on anti-tuberculosis drug-induced hepatotoxicity Source: Eur Respir J 2006; 28: Suppl. 50, 505s Year: 2006
Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Endocrinologic toxicity Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019
Immunosuppressive therapy after human lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105 Year: 2003
Differential diagnosis of drug-induced toxicity and infectious disorder in haematological malignancies Source: Annual Congress 2009 - PG7 Drug-induced pulmonary toxicity Year: 2009
Immunosuppressive therapy after human lung transplantation Source: Eur Respir J 2004; 23: 159-171 Year: 2004
Severe adverse effects of antitubercular drugs and patient management Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011
Cytochrome P450 pharmacogenetics: a possible predictor of pulmonary drug induced toxicity? Source: Eur Respir J 2007; 30: Suppl. 51, 488s Year: 2007
Favorable human safety, pharmacokinetics and pharmacodynamics of the autotaxin inhibitor GLPG1690, a potential new treatment in COPD Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015
Late Breaking Abstract - Anti-inflammatory activity of novel transtilbene sulfonamide analogues as potential novel therapeutic agents for inflammatory lung disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Drug-induced lung damage: a role for genomics in its prevention? Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006
Cardiovascular adverse effects during itraconazole therapy Source: Eur Respir J 2008; 32: 240 Year: 2008
Late Breaking Abstract - The outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021
Drug-induced pulmonary toxicity: a role for anti-oxidants in oxidative stress Source: Annual Congress 2009 - PG7 Drug-induced pulmonary toxicity Year: 2009
Hypersensitivity pneumonitis associated with the use of temozolomide Source: Eur Respir J 2009; 33: 931-934 Year: 2009
Management of chemotherapy-induced anemia in patients with lung cancer (LC): A comparative study of erythropoietic agents Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Molecular epidemiology of adverse respiratory effects: A high-throughput screening method to detect biomarkers of genotoxic exposure Source: Annual Congress 2010 - Causal factors and mechanisms of outdoor air pollution and nanoparticulates Year: 2010